Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder 26-02-2025, 04:00

Junshi Biosciences Announces Initiation of Phase 3 Study of Tifcemalimab plus Toripalimab for Treatment of Limited-stage Small Cell Lung Cancer 29-06-2023, 12:59

Philips launches new-AI enabled innovations at #RSNA23 that free up healthcare providers to focus on patient care 26-11-2023, 21:00